Trial Site Detail

 

Drug:
Imatinib
Trial:
Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (ImadGist)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Centre Oscar Lambret - Lille

     
Lille , Nord 59020
France

 

Principal Investigator:
 Nicolas Penel, Pr
Contact:
 Nicolas PENEL, Pr +33 3 20 29 59 20 n-penel@o-lambret.fr
Activation Status of this Site:
 Closed
Notes about this Site:
Centre Oscar Lambret - Lille Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.